Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 3 × Has announcements × Passive Cutaneous Anaphylaxis × Clear all

Sponsor

Interventions

Carboplatin 33 Cisplatin 28 pembrolizumab 27 Paclitaxel 26 Pemetrexed 20 Gemcitabine 19 Nivolumab 18 Rituximab 15 Dexamethasone 15 Ipilimumab 12 Fluorouracil 11 Docetaxel 11 Cyclophosphamide 11 durvalumab 10 Lenalidomide 9 Capecitabine 9 Bevacizumab 9 olaparib 8 atezolizumab 8 Doxorubicin 8 Cytarabine 8 130-nm albumin-bound paclitaxel 8 daratumumab 7 Prednisone 7 Leucovorin 7 Etoposide 7 Bortezomib 7 venetoclax 6 osimertinib 6 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡